Statistics for Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials

Total visits

views
Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials 1

Total visits per month

views
October 2024 1
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Journal Article.pdf 14

Top country views

views
India 1